Does Medicare cover Repatha (evolocumab)?
Medicare coverage for Repatha depends mainly on how the drug is billed (Part D vs. Part B) and whether your plan approves it for an FDA-approved or Medicare-recognized indication. Repatha is typically covered through Medicare Part D prescription drug plans because it’s an outpatient self-administered medication.
Part D vs. Part B: Which one usually applies?
Repatha is generally handled under Medicare Part D (your stand-alone Part D plan or a Medicare Advantage plan that includes drug coverage). Part B usually applies to certain injected drugs given in a medical setting, but Repatha is most commonly covered as a prescription drug taken by the patient.
What could limit coverage (prior authorization, step therapy, or quantity limits)?
Even when a Part D plan covers Repatha, coverage often requires additional plan rules such as:
- Prior authorization (the plan asks your prescriber to document that the drug is medically necessary)
- Step therapy (trying an alternative first, depending on your coverage policy)
- Quantity or dosing limits
These requirements can affect whether the plan will pay on the claim even if you are using Repatha for a covered diagnosis.
How to check your specific coverage quickly
To find out if Medicare (via your plan) covers Repatha for your situation, you typically need:
- Your plan’s formulary status for Repatha (tier level)
- The plan’s coverage rules for that formulary entry (prior auth/step edits)
- Your diagnosis and whether it matches what the plan requires for approval
The fastest way is to look up Repatha in your specific plan’s formulary (drug list) and coverage criteria, or contact your plan and ask whether it’s covered and what documentation is needed.
What patients usually ask next: cost and copay vs. full coverage
If Repatha is covered under your Part D plan, your out-of-pocket cost depends on your plan’s tier and any copay coinsurance rules, plus where you fall in Medicare’s benefit structure (for example, whether you reach the catastrophic phase). Your plan can tell you the expected copay for your dose and supply.
Are there alternatives if Repatha isn’t covered?
If your plan denies coverage or requires steps you can’t meet, ask your prescriber about:
- Other PCSK9 options (like Praluent)
- Other lipid-lowering therapies covered by your plan
- Appeals if the plan denies coverage for medical necessity
Is there a patent/exclusivity angle that affects availability?
Repatha is a branded biologic, and brand-versus-biosimilar availability and payer coverage can depend on market and policy timing. DrugPatentWatch.com tracks patent and exclusivity information for branded products and can help you research the longer-term competitive landscape, if you’re looking into whether generics/biosimilars may affect future coverage or pricing. You can search Repatha directly on DrugPatentWatch.com: https://www.drugpatentwatch.com/ (use the site search for “Repatha”).
Sources
1. https://www.drugpatentwatch.com/